Literature DB >> 27217427

Antiretroviral Therapy Initiation Following Policy Changes: Observations From China.

Li Li1, Guoping Ji2, Chunqing Lin3, Li-Jung Liang3, Chiao-Wen Lan3.   

Abstract

China's HIV/AIDS treatment policies have been evolving over the preceding decade. This study describes patterns of antiretroviral therapy (ART) initiation for a sample of people living with HIV/AIDS (PLHIV) in rural Anhui, China, where most PLHIV were infected via paid plasma donation during the 1990s. A total of 481 PLHIV who were receiving ART were included in our analyses. Times between HIV diagnosis and the initiation of ART were examined relative to the time points when major ART-related policies changed in China. More than half (53%) of PLHIV who had been diagnosed by 2003 received ART within 6 months, whereas 93% of PLHIV who had been diagnosed in 2010 or later received ART within 6 months. The study results provide additional support that the "Four Frees and One Care" policy in 2003 and the relaxation of ART eligibility in 2010 have facilitated the initiation of treatment for PLHIV in China.
© 2016 APJPH.

Entities:  

Keywords:  China; HIV; antiretroviral therapy; policy; treatment outcome

Mesh:

Substances:

Year:  2016        PMID: 27217427      PMCID: PMC5067940          DOI: 10.1177/1010539516650721

Source DB:  PubMed          Journal:  Asia Pac J Public Health        ISSN: 1010-5395            Impact factor:   1.399


  13 in total

1.  Correlates of HIV infection among former blood/plasma donors in rural China.

Authors:  Guoping Ji; Roger Detels; Zunyou Wu; Yueping Yin
Journal:  AIDS       Date:  2006-02-28       Impact factor: 4.177

2.  The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China.

Authors:  Fujie Zhang; Zhihui Dou; Lan Yu; Jiahong Xu; Jin Hua Jiao; Ning Wang; Ye Ma; Yan Zhao; Hongxin Zhao; Ray Y Chen
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

Review 3.  Current progress of China's free ART program.

Authors:  Fu Jie Zhang; Jennifer Pan; Lan Yu; Yi Wen; Yan Zhao
Journal:  Cell Res       Date:  2005 Nov-Dec       Impact factor: 25.617

4.  CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Authors:  Gilbert R Kaufmann; Luc Perrin; Guiseppe Pantaleo; Milos Opravil; Hansjakob Furrer; Amalio Telenti; Bernard Hirschel; Bruno Ledergerber; Pietro Vernazza; Enos Bernasconi; Martin Rickenbach; Matthias Egger; Manuel Battegay
Journal:  Arch Intern Med       Date:  2003-10-13

5.  Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09.

Authors:  Zhihui Dou; Ray Y Chen; Jiahong Xu; Ye Ma; Jin Hua Jiao; Stephen Durako; Yan Zhao; Decai Zhao; Hua Fang; Fujie Zhang
Journal:  Int J Epidemiol       Date:  2010-12       Impact factor: 7.196

6.  Design and implementation of a China comprehensive AIDS response programme (China CARES), 2003-08.

Authors:  Mengjie Han; Qingfeng Chen; Yang Hao; Yifei Hu; Dongmei Wang; Yan Gao; Marc Bulterys
Journal:  Int J Epidemiol       Date:  2010-12       Impact factor: 7.196

7.  China AIDS policy implementation: reversing the HIV/AIDS epidemic by 2015.

Authors:  Zunyou Wu; Yu Wang; Roger Detels; Mary Jane Rotheram-Borus
Journal:  Int J Epidemiol       Date:  2010-12       Impact factor: 7.196

8.  The Chinese free antiretroviral treatment program: challenges and responses.

Authors:  Fujie Zhang; Jessica E Haberer; Yu Wang; Yan Zhao; Ye Ma; Decai Zhao; Lan Yu; Eric P Goosby
Journal:  AIDS       Date:  2007-12       Impact factor: 4.177

9.  Setting ART initiation targets in response to changing guidelines: The importance of addressing both steady-state and backlog.

Authors:  Catherine Martin; Nicolette P Naidoo; W D Francois Venter; Ambereen Jaffer; Pierre M Barker
Journal:  S Afr Med J       Date:  2014-05-12

Review 10.  Evolution of China's response to HIV/AIDS.

Authors:  Zunyou Wu; Sheena G Sullivan; Yu Wang; Mary Jane Rotheram-Borus; Roger Detels
Journal:  Lancet       Date:  2007-02-24       Impact factor: 202.731

View more
  6 in total

1.  Spousal role and caregiver burden in HIV affected families in Anhui Province, China.

Authors:  Julie Hsieh; Li Li; Chunqing Lin; Sitong Luo; Guoping Ji
Journal:  AIDS Care       Date:  2017-03-09

2.  The Development of a Personalized Symptom Management Mobile Health Application for Persons Living with HIV in China.

Authors:  Shuyu Han; Yaolin Pei; Lina Wang; Yan Hu; Xiang Qi; Rui Zhao; Lin Zhang; Wenxiu Sun; Zheng Zhu; Bei Wu
Journal:  J Pers Med       Date:  2021-04-25

3.  Dataset of cognitive behavioral intervention for persons living with HIV in China: A randomized pilot trial.

Authors:  Shuyu Han; Yan Hu; Zheng Zhu; Bei Wu
Journal:  Data Brief       Date:  2020-03-31

4.  The value and implementation of routine ophthalmic examination in the era of HAART.

Authors:  Wangting Li; Xiaoli Wang; Lanqin Zhao; Duoru Lin; Yahan Yang; Zhenzhen Liu; Xiaohang Wu; Jinghui Wang; Yi Zhu; Chuan Chen; Xiayin Zhang; Ruixin Wang; Ruiyang Li; Xiaoman Huang; Wenyong Huang; Haotian Lin
Journal:  EClinicalMedicine       Date:  2020-12-22

5.  Effects of a symptom management intervention based on group sessions combined with a mobile health application for persons living with HIV in China: A randomized controlled trial.

Authors:  Shuyu Han; Yaolin Pei; Rui Zhao; Yan Hu; Lin Zhang; Xiang Qi; Zheng Zhu; Wenxiu Sun; Bei Wu
Journal:  Int J Nurs Sci       Date:  2021-07-20

6.  A comparative analysis on characteristics and mortalities of four key transmission populations on antiretroviral therapy: a retrospective cohort study in Northwest China.

Authors:  Shuo Feng; Zirong Zhu; Pengju Yang; Juan Jin; Huihui Tuo; Ning Wang; Ruimin Bai; Yan Sun; Liumei Song; Xiu Zhang; Shengbang Wang; Qiqi Duan; Yingjian Huang; Yan Zheng; Songhua Xu
Journal:  BMC Infect Dis       Date:  2022-03-28       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.